Literature DB >> 7627502

Efficacy of glutamine-enriched enteral nutrition in an experimental model of mucosal ulcerative colitis.

T Fujita1, K Sakurai.   

Abstract

Intact intestinal epithelium and associated lymphatic tissue act as body defences against luminal toxins. This barrier may become threatened or compromised in inflammatory bowel disease, leading to an increase in mucosal permeability and subsequent translocation of endotoxins. The effect of oral glutamine on gut mucosal ornithine decarboxylase activity and on endotoxin levels in portal vein blood was studied in a guinea-pig model of carrageenan-induced colitis. Despite failure to show induction of ornithine decarboxylase activity by glutamine administration, the mean endotoxin level of portal vein blood in guinea-pigs fed a glutamine-enriched elemental diet was 25.3 pg/ml compared with 71.2 pg/ml in animals given a standard elemental diet (P < 0.01). A glutamine-enriched elemental diet may be therapeutically beneficial in patients with inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7627502     DOI: 10.1002/bjs.1800820611

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions.

Authors:  RadhaKrishna Rao; Geetha Samak
Journal:  J Epithel Biol Pharmacol       Date:  2012-01

2.  Glutamine and whey protein improve intestinal permeability and morphology in patients with Crohn's disease: a randomized controlled trial.

Authors:  Jaya Benjamin; Govind Makharia; Vineet Ahuja; K D Anand Rajan; Mani Kalaivani; Siddhartha Datta Gupta; Yogendra Kumar Joshi
Journal:  Dig Dis Sci       Date:  2011-10-26       Impact factor: 3.199

Review 3.  Dietary factors in the modulation of inflammatory bowel disease activity.

Authors:  Shinil Shah
Journal:  MedGenMed       Date:  2007-03-27

4.  Prophylactic effect of dietary glutamine supplementation on interleukin 8 and tumour necrosis factor alpha production in trinitrobenzene sulphonic acid induced colitis.

Authors:  C K Ameho; A A Adjei; E K Harrison; K Takeshita; T Morioka; Y Arakaki; E Ito; I Suzuki; A D Kulkarni; A Kawajiri; S Yamamoto
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

5.  Glutamine supplementation in sick children: is it beneficial?

Authors:  Elise Mok; Régis Hankard
Journal:  J Nutr Metab       Date:  2011-11-14

6.  Glutamine relieves oxidative stress through PI3K/Akt signaling pathway in DSS-induced ulcerative colitis mice.

Authors:  Shuguang Yan; Yi Hui; Jingtao Li; Xiaofan Xu; Qian Li; Hailiang Wei
Journal:  Iran J Basic Med Sci       Date:  2020-09       Impact factor: 2.699

7.  Prophylactic administration of topical glutamine enhances the capability of the rat colon to resist inflammatory damage.

Authors:  Eran Israeli; Eduard Berenshtein; Dov Wengrower; Larisa Aptekar; Ron Kohen; Gershom Zajicek; Eran Goldin
Journal:  Dig Dis Sci       Date:  2004-10       Impact factor: 3.199

8.  Colonic ornithine decarboxylase in inflammatory bowel disease: ileorectal activity gradient, guanosine triphosphate stimulation, and association with epithelial regeneration but not the degree of inflammation and clinical features.

Authors:  Hubert Allgayer; Ulla Roisch; Elmar Zehnter; Dieter J Ziegenhagen; Hans P Dienes; Wolfgang Kruis
Journal:  Dig Dis Sci       Date:  2006-12-14       Impact factor: 3.487

9.  Enteral nutrition combined with glutamine promotes recovery after ileal pouch-anal anastomosis in rats.

Authors:  Yan-Yan Xu; An-Qi He; Gang Liu; Kai-Yu Li; Jian Liu; Tong Liu
Journal:  World J Gastroenterol       Date:  2018-02-07       Impact factor: 5.742

10.  Low intestinal glutamine level and low glutaminase activity in Crohn's disease: a rational for glutamine supplementation?

Authors:  Bernd Sido; Cornelia Seel; Achim Hochlehnert; Raoul Breitkreutz; Wulf Dröge
Journal:  Dig Dis Sci       Date:  2006-11-01       Impact factor: 3.487

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.